<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39382478</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1745-5065</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Women's health (London, England)</Title><ISOAbbreviation>Womens Health (Lond)</ISOAbbreviation></Journal><ArticleTitle>No one listens to us, we know this, so we participated: Qualitative evidence from menstruation research during the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>17455057241285189</StartPage><MedlinePgn>17455057241285189</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17455057241285189</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/17455057241285189</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">We created a survey to assess menstrual side effects after COVID-19 vaccination when we noticed news stories that denied or discounted the experiences of tens of thousands of menstruating and formerly menstruating people who reported experiencing bleeding changes. This survey had an unprecedented response hundreds of times higher than we had anticipated (<i>n</i> = 101,824).</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">We investigated what motivated our sample to participate without remuneration to understand both general motivations for survey participation as well as why this survey captured the interest of so many.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">We used open-ended responses from our online, mixed-method survey collected from April to October 2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Using computer-assisted qualitative data analysis tools in R, we conducted a thematic analysis on open-ended responses. We used topic modeling to cluster the data, synthesize responses across 22,737 participants, and inform the themes summarizing the responses to "What is your interest in this project?" We compared and contrasted responses across groups (racial identity, ethnicity, gender) to examine whether the themes were representative across the demographic groups in our study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The themes that characterized participants' interest in participating were vaccine effects and women's/people's health, personal experience related to the vaccine, and a love for science and data. We compared responses among demographic subgroups to avoid an overfocus on majority group responses and found the themes were reflected across each group. Lastly, we found our themes reflected multiple types of altruism.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">These results were important in showing how emergent research that focuses on the concerns of potential participants can encourage high response rates from both marginalized and majority communities. Inclusive practices and familiarity with the research team built credibility that engendered trust with the public.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Junkins</LastName><ForeName>Eleanor J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-2878-6290</Identifier><AffiliationInfo><Affiliation>Department of Psychology, College of Liberal Arts &amp; Sciences, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chehab</LastName><ForeName>Samar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychology, College of Liberal Arts &amp; Sciences, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Katharine Mn</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-8894-9816</Identifier><AffiliationInfo><Affiliation>Department of Anthropology, Tulane University, New Orleans, LA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anthropology, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Studies of Women, Gender, and Sexuality, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clancy</LastName><ForeName>Kathryn Bh</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Anthropology, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Ecology, Evolution, and Conservation, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beckman Institute of Advanced Science &amp; Technology, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 CA190194</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Womens Health (Lond)</MedlineTA><NlmUniqueID>101271249</NlmUniqueID><ISSNLinking>1745-5057</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008598" MajorTopicYN="Y">Menstruation</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="N">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText><b>No one listens to us, we know this, so we participated: Qualitative evidence from menstruation research during the COVID-19 pandemic</b>Despite the success of the COVID-19 vaccine rollout, trust in science was put to the test as tens of thousands of people who currently menstruate or people who used to menstruate (e.g., postmenopausal) reported experiencing changes to their menstrual bleeding or new bleeding. News stories and medical professionals denied or discounted their experiences. In response, we created a survey to assess menstrual side effects after COVID-19 vaccination. The survey had an unprecedented response. Therefore, we investigated our sample’s motivations, in particular, because this was unpaid research. We used computer-assisted tools to synthesize open-ended answers to “How did you hear about this project” and “What is your interest in this study?” To understand what led people to participate, we found participants’ interests were vaccine effects and women’s/people’s health, personal experience related to the vaccine, and a love for science and data. We compared responses among demographic subgroups to avoid an overfocus on the majority responses (e.g., cisgender women or White people), and we found our themes reflected multiple types of altruism. These results were important in showing how research that is responsive to public needs encourages high responses from both marginalized and majority communities. We utilized inclusivity and familiarity to build credibility and create online presences to engender trust with the public. Future clinical research can be informed by our findings. We show strategies for doing ethical clinical research by speaking to people from all groups who may be affected.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">community participation</Keyword><Keyword MajorTopicYN="N">cross sectional survey</Keyword><Keyword MajorTopicYN="N">cultural diversity</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword></KeywordList><CoiStatement>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39382478</ArticleId><ArticleId IdType="pmc">PMC11465293</ArticleId><ArticleId IdType="doi">10.1177/17455057241285189</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fitzpatrick MC, Moghadas SM, Panday A, et al.. Two years of U.S. COVID-19 vaccines have prevented millions of hospitalizations and deaths. New York: The Commonwealth Fund, 2022.</Citation></Reference><Reference><Citation>
Haelle T. Science [cited 21 December
2023]. Why is it so hard to compensate people for serious vaccine side effects?, https://www.nationalgeographic.com/science/article/why-is-it-so-hard-to-compensate-people-for-serious-vaccine-side-effects (2022, accessed 21 December 2023).</Citation></Reference><Reference><Citation>Lee KMN, Junkins EJ, Luo C, et al.. Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination. Sci Adv 2022; 8(28): eabm7201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9286513</ArticleId><ArticleId IdType="pubmed">35857495</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueda-Fernández M, Melguizo-Rodríguez L, Costela-Ruiz VJ, et al.. The current status of COVID-19 vaccines. A scoping review. Drug Discov Today 2022; 27(11): 103336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9389839</ArticleId><ArticleId IdType="pubmed">35995361</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvergne A, Woon EV, Male V. Effect of COVID-19 vaccination on the timing and flow of menstrual periods in two cohorts. Front Reprod Health 2022; 4: 952976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9580734</ArticleId><ArticleId IdType="pubmed">36303656</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvergne A, Kountourides G, Argentieri MA, et al.. A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease. iScience 2023; 26(4): 106401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10015085</ArticleId><ArticleId IdType="pubmed">36987520</ArticleId></ArticleIdList></Reference><Reference><Citation>Blix K, Laake I, Juvet L, et al.. Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women. Sci Adv 2023; 9(38): eadg1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10516485</ArticleId><ArticleId IdType="pubmed">37738335</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman A, Boniface ER, Benhar E, et al.. Association between menstrual cycle length and coronavirus disease 2019 (COVID-19) vaccination: a US cohort. Obstet Gynecol 2022; 139(4): 481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8936155</ArticleId><ArticleId IdType="pubmed">34991109</ArticleId></ArticleIdList></Reference><Reference><Citation>Male V. Effect of COVID-19 vaccination on menstrual periods in a retrospectively recruited cohort. medRXiv 2021; 2021: 2021-11.</Citation></Reference><Reference><Citation>Nazir M, Asghar S, Rathore MA, et al.. Menstrual abnormalities after COVID-19 vaccines: a systematic review. Vacunas 2022; 23: S77–S87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9294036</ArticleId><ArticleId IdType="pubmed">35873308</ArticleId></ArticleIdList></Reference><Reference><Citation>Qashqari FSI, Dahlawi M, Assaggaf HM, et al.. Effect of the COVID-19 vaccine on the menstrual cycle among females in Saudi Arabia. Ethiop J Health Sci 2022; 32(6): 1083–1092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9692149</ArticleId><ArticleId IdType="pubmed">36475264</ArticleId></ArticleIdList></Reference><Reference><Citation>Trogstad L, Laake I, Robertson AH, et al.. Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination. Vaccine 2023; 41(36): 5271–5282.</Citation><ArticleIdList><ArticleId IdType="pubmed">37451876</ArticleId></ArticleIdList></Reference><Reference><Citation>
Yates I, Byrne J, Donahue S, et al.. Representation in clinical trials: a review on reaching underrepresented populations in research. Association of Clinical Research Professionals, https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research (2020, accessed 12 April 2023).</Citation></Reference><Reference><Citation>Tamlyn AL, Tjilos M, Bosch NA, et al.. At the intersection of trust and mistrust: a qualitative analysis of motivators and barriers to research participation at a safety-net hospital. Health Expect 2023; 26(3): 1118–1126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154811</ArticleId><ArticleId IdType="pubmed">36896842</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrd GS, Edwards CL, Kelkar VA, et al.. Recruiting intergenerational African American males for biomedical research studies: a major research challenge. J Natl Med Assoc 2011; 103(6): 480–487.</Citation><ArticleIdList><ArticleId IdType="pubmed">21830630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins CH, Schindler SE, Morris JC. Addressing health disparities among minority populations: why clinical trial recruitment is not enough. JAMA Neurol 2020; 77(9): 1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983552</ArticleId><ArticleId IdType="pubmed">32539100</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al.. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377–381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2022.</Citation></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19(6): 349–357.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ooms J. cld2: Google’s Compact Language Detector 2, https://CRAN.R-project.org/package=cld2 (2020, accessed 10 March 2022).</Citation></Reference><Reference><Citation>Mayring P. Qualitative content analysis. Forum: Qual Social Res 2004; 1(2): 159–176.</Citation></Reference><Reference><Citation>Pope C, Mays N. Qualitative research in health care, 3rd ed. Malden, Mass: Blackwell Pub./BMJ Books, 2006.</Citation></Reference><Reference><Citation>Ryan GW, Bernard HR. Techniques to identify themes. Field Methods 2003; 15(1): 85–109.</Citation></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3(2): 77–101.</Citation></Reference><Reference><Citation>Grün B, Hornik K. Topicmodels: an R package for fitting topic models. J Stat Softw 2011; 40(13): 1–30.</Citation></Reference><Reference><Citation>Silge J, Robinson D. Tidytext: text mining and analysis using tidy data principles in R. JOSS 2016; 1(3): 37.</Citation></Reference><Reference><Citation>Bazeley P. Qualitative data analysis: practical strategies, 2nd ed. London: SAGE Publications Ltd., 2021.</Citation></Reference><Reference><Citation>Richards L. Handling qualitative data: a practical guide. 4th ed. London: SAGE, 2021.</Citation></Reference><Reference><Citation>Chin LJ, Berenson JA, Klitzman RL. Typologies of altruistic and financial motivations for research participation: a qualitative study of MSM in HIV vaccine trials. J Empir Res Hum Res Ethics 2016; 11(4): 299–310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5334779</ArticleId><ArticleId IdType="pubmed">28251864</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey N. Varieties of altruism—and the common ground between them. Soc Res 1997; 64(2): 199–209.</Citation></Reference><Reference><Citation>
Hvitfeldt E. Textdata: download and load various text datasets, https://CRAN.R-project.org/package=textdata (2020, accessed 1 May 2022).</Citation></Reference><Reference><Citation>
Cooney E.
Who gets hospitalized for COVID-19? Report shows differences by race and sex, https://www.statnews.com/2020/04/09/hospitalized-covid-19-patients-differences-by-race-and-sex/ (2020, accessed 12 April 2023).</Citation></Reference><Reference><Citation>Krouse HJ. COVID-19 and the widening gap in health inequity. Otolaryngol Head Neck Surg 2020; 163(1): 65–66.</Citation><ArticleIdList><ArticleId IdType="pubmed">32366172</ArticleId></ArticleIdList></Reference><Reference><Citation>Baah FO, Teitelman AM, Riegel B. Marginalization: conceptualizing patient vulnerabilities in the framework of social determinants of health—an integrative review. Nurs Inq 2019; 26(1): e12268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6342665</ArticleId><ArticleId IdType="pubmed">30488635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibb JK, DuBois LZ, Williams S, et al.. Sexual and gender minority health vulnerabilities during the COVID -19 health crisis. Am J Hum Biol 2020; 32(5): 23499.</Citation><ArticleIdList><ArticleId IdType="pubmed">32910838</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess CM, Batchelder AW, Sloan CA, et al.. Impact of the COVID-19 pandemic on transgender and gender diverse health care. Lancet Diabetes Endocrinol 2021; 9(11): 729–731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8463012</ArticleId><ArticleId IdType="pubmed">34570996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugarman J, Kass NE, Goodman SN, et al.. What patients say about medical research. IRB Ethics Hum Res 1998; 20(4): 1.</Citation><ArticleIdList><ArticleId IdType="pubmed">11657084</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis NA. What counts as good science? How the battle for methodological legitimacy affects public psychology. Am Psychol 2021; 76(8): 1323–1333.</Citation><ArticleIdList><ArticleId IdType="pubmed">35113596</ArticleId></ArticleIdList></Reference><Reference><Citation>Anfara VA, Brown KM, Mangione TL. Qualitative analysis on stage: making the research process more public. Educ Res 2002; 31(7): 28–38.</Citation></Reference><Reference><Citation>Jackson K, Paulus T, Woolf N. The walking dead genealogy: unsubstantiated criticisms of Qualitative Data Analysis Software (QDAS) and the failure to put them to rest. Qual Rep 2018; 23(13): 74–91.</Citation></Reference><Reference><Citation>Borno H, Siegel A, Ryan C. The problem of representativeness of clinical trial participants: understanding the role of hidden costs. J Health Serv Res Policy 2016; 21(3): 145–146.</Citation><ArticleIdList><ArticleId IdType="pubmed">26888478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy-Martin T, Curtis S, Faries D, et al.. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 2015; 16(1): 495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632358</ArticleId><ArticleId IdType="pubmed">26530985</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Spall HGC, Toren A, Kiss A, et al.. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007; 297(11): 1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">17374817</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden LR, El Sahly HM, Essink B, et al.. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021; 384(5): 403–416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, et al.. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383(27): 2603–2615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Averitt AJ, Weng C, Ryan P, et al.. Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations. NPJ Digit Med 2020; 3(1): 67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214444</ArticleId><ArticleId IdType="pubmed">32411828</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wong VC, Steiner PM. Moving from What Works to What Replicates: A New Framework for Evidence Based Policy Analysis [Internet]. ZPID (Leibniz Institute for Psychology Information); 2019 [cited 2024 September 20]. https://www.psycharchives.org/handle/20.500.12034/2025</Citation></Reference><Reference><Citation>Carroll KM, Nich C, McLellan AT, et al.. ‘Research’ versus ‘real-world’ patients: representativeness of participants in clinical trials of treatments for cocaine dependence. Drug Alcohol Depend 1999; 54(2): 171–177.</Citation><ArticleIdList><ArticleId IdType="pubmed">10217557</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher JA, Kalbaugh CA. Challenging assumptions about minority participation in US clinical research. Am J Public Health 2011; 101(12): 2217–2222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3222419</ArticleId><ArticleId IdType="pubmed">22021285</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobat NH, Gal M, Butler CC, et al.. Talking to the people that really matter about their participation in pandemic clinical research: a qualitative study in four European countries. Health Expect 2018; 21(1): 387–395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5750735</ArticleId><ArticleId IdType="pubmed">28960624</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>